Numeric Investors’s Medicines Co MDCO Stock Holding History

Numeric Investors’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-66,600	Closed	-$2.26M	–	1225
2016 Q4	$2.26M	Sell	66,600 -51,600	-44%	-$1.83M	0.02%	477
2016 Q3	$4.46M	Buy	+118,200	New	+$4.45M	0.04%	336
2015 Q2	–	Sell	-25,900	Closed	-$726K	–	1144
2015 Q1	$726K	Buy	+25,900	New	+$728K	0.01%	551

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Numeric Investors's MDCO Position: Q1 2017 in Review

Numeric Investors sold out of Medicines Co (MDCO) in Q1 2017, closing a stake of 66,600 shares — an estimated $2.26M sold.

Numeric Investors first reported a position in MDCO in Q1 2015 and held it in 3 quarters. The position peaked at $4.46M in Q3 2016. 220 funds tracked by Wall St. Rank hold MDCO as of Q1 2017.

Numeric Investors reported no remaining Medicines Co position as of Q1 2017 after selling out during the quarter.
Numeric Investors sold 66,600 Medicines Co shares in Q1 2017, an estimated $2.26M.
Numeric Investors first reported a position in Medicines Co in Q1 2015 and held it in 3 quarters.
Numeric Investors's Medicines Co position peaked at $4.46M in Q3 2016.
220 funds tracked by Wall St. Rank held Medicines Co as of Q1 2017.

Based on Numeric Investors's 13F filing for Q1 2017, filed 15 May 2017.